Role of MRI in Active Surveillance of Prostate Cancer

被引：0
|
作者：
Chappidi, Meera R. [1 ]
Lin, Daniel W. [1 ]
Westphalen, Antonio C. [1 ,2 ,3 ]
机构：
[1] Univ Washington, Sch Med, Dept Urol, Seattle, WA USA
[2] Univ Washington, Sch Med, Dept Radiol, 1959 NE Pacific St, Seattle, WA 98195 USA
[3] Univ Washington, Sch Med, Dept Radiat Oncol, Seattle, WA USA
来源：
SEMINARS IN ULTRASOUND CT AND MRI | 2025年 / 46卷 / 01期
关键词：
CLINICAL STAGE; MEN; BIOPSY; PROGRESSION; OUTCOMES;
D O I：
10.1053/j.sult.2024.11.002
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Magnetic resonance imaging (MRI) plays an important role in the management of patients with prostate cancer on active surveillance. In this review, we will explore the incorporation of MRI into active surveillance protocols, detailing its impact on clinical decision-making and patient management and discussing how it aligns with current guidelines and practice patterns. The role of MRI in this patient population continues to evolve over time, and we will discuss some of the recent advancements in the field and highlight potential areas for future research endeavors.
引用
收藏
页码：31 / 44
页数：14
相关论文
共 50 条
  • [31] ERG and PTEN Role on Active Surveillance for Low-Risk Prostate Cancer in the Multiparametric MRI Era
    Yorioka, Marco Aurelio Watanabe
    Murta, Claudio Bovolenta
    Leite, Katia Ramos Moreira
    Cardili, Leonardo
    de Mello, Evandro Sobroza
    Fazoli, Arnaldo Jose de Carvalho
    Cordeiro, Mauricio Dener
    Coelho, Rafael Ferreira
    Viana, Publio Cesar Cavalcante
    Kohama, Cesar Sadao Nicolino
    Nahas, William Carlos
    Pontes-Junior, Jose
    PROSTATE, 2025, 85 (04): : 364 - 373
  • [32] Active surveillance of prostate cancer
    Hammerer, Peter
    Manka, Lukas
    ONKOLOGE, 2020, 26 (11): : 1069 - 1078
  • [33] Active surveillance for prostate cancer
    Dariane, C.
    PROGRES EN UROLOGIE, 2015, 25 (14): : 884 - 887
  • [34] Interaction of MRI and active surveillance in prostate cancer: Time to re- evaluate the active surveillance inclusion criteria
    Venderbos, Lionne D. F.
    Luiting, Henk
    Hogenhout, Renee
    Roobol, Monique J.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (02) : 82 - 87
  • [35] Active Surveillance of Prostate Cancer
    Choyke, Peter L.
    Loeb, Stacy
    ONCOLOGY-NEW YORK, 2017, 31 (01): : 67 - 70
  • [36] Active surveillance for prostate cancer
    Romero-Otero, Javier
    Garcia-Gomez, Borja
    Duarte-Ojeda, Jose M.
    Rodriguez-Antolin, Alfredo
    Vilaseca, Antoni
    Carlsson, Sigrid V.
    Touijer, Karim A.
    INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 (03) : 211 - 218
  • [37] Active surveillance in prostate cancer
    Erne, E.
    Kaufmann, S.
    Nikolaou, K.
    Stenzl, A.
    Bedke, J.
    UROLOGE, 2019, 58 (05): : 511 - 517
  • [38] Active surveillance of prostate cancer
    Ploussard, G.
    Hennequin, C.
    Rozet, F.
    CANCER RADIOTHERAPIE, 2017, 21 (6-7): : 437 - 441
  • [39] Active Surveillance for Prostate Cancer
    Thompson, Ian M.
    Klotz, Laurence
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (21): : 2411 - 2412
  • [40] Prostate cancer and active surveillance
    Abrahamsson, Per-Anders
    CONTROVERSIES IN THE TREATMENT OF PROSTATE CANCER, 2008, 41 : 1 - 6
12345